fda removes semaglutide from drug shortage list february 2025 ends shortage, closing the door on compounded Wegovy, Ozempic Hims & Hers stock falls

This ensures researchers get peptides in a timely manner

3.2 GLP-1RAs in psoriatic arthritis The therapeutic landscape of PsA is currently dominated by targeted agents that inhibit key inflammatory pathways, including TNF inhibitors (e.g., adalimumab, etanercept), IL17 inhibitors (e.g., secukinumab, ixekizumab), IL-23 inhibitors (e.g., guselkumab, risankizumab), and Janus kinase (JAK) inhibitors such as upadacitinib and tofacitinib (62)

Accessibility During Shortages : Compounded semaglutide has been a popular alternative during periods when FDA-approved options were in limited supply

Each patients response to the medication is unique, and regular follow-up visits are necessary to ensure the medication is working effectively and that any potential side effects are addressed

The medication works by increasing the release of insulin, a hormone that helps lower blood sugar